Table 1.
Target | Compounds | Animal/organs | Effect | References |
---|---|---|---|---|
Antioxidant effect | TCR | Rat heart | Lipid peroxidation; | Jayalakshmi and Devaraj, 2004 [28] |
Activity of marker enzymes; | ||||
Antioxidant enzymes; | ||||
Oxygen uptake; | ||||
Respiratory coupling ratio | ||||
| ||||
Positive inotropic effect | WS 1442 | Human myocardial tissue | cAMP-independent mechanism; | Schwinger et al., 2000 [31] |
Sarcolemmal Na+/K+-ATPase; | ||||
Sodium pump; | ||||
Intracellular Ca2+ concentration; | ||||
| ||||
Anti-inflammatory effect | AEC | Rat heart | Nitritive stress; | Vijayan et al., 2012 [37] |
Oxidative stress; | ||||
iNOS expression; | ||||
COX-2; | ||||
Lipid peroxidation; | ||||
Cytochrome c; | ||||
| ||||
Anti-cardiac remodeling effect | WS 1442 | Rat | LV chamber volumes (VOL); | Hwang et al., 2008 [41] |
Relative wall thickness; | ||||
Vcfc; | ||||
| ||||
Antiplatelet aggregation | Crataegus aronia syn. Azarolus (L) | Rat blood | Bleeding time; | Abdullah et al., 2012 [45] |
Platelet aggregation; | ||||
Serum levels of TXB2; | ||||
| ||||
Vasodilating effect | WS 1442 | Isolated rings of rat aorta | Endothelium-dependent, | Brixuis et al., 2006 [50] |
NO-mediated vasorelaxation; | ||||
eNOS phosphorylation; | ||||
Crataegus microphylla CM extract | Rat thoracic aorta | Endothelium-dependent relaxation; | Gökçe et al., 2013 [52] | |
Vascular contraction; | ||||
iNOS expression; | ||||
Plasma levels of TNF-α, IL-6; | ||||
Lipid peroxidation; | ||||
CE | Rat aorta | Endothelium-dependent nitric oxide(NO)-mediated relaxation; | Kim et al., 2000 [54] | |
Tetraethylammonium-sensitive K+ channels; | ||||
| ||||
Endothelial protection | WS 1442 | Rat main mesenteric arteries | Prostanoid-mediated contractile responses; | Idris-Khodja et al., 2012 [63] |
Oxidative stress; | ||||
COX-1 and COX-2; | ||||
| ||||
Protect I/R injury | WS 1442 | Rat myocardium | Contractile function; | Veveris et al., 2004 [67] |
Infarct size; | ||||
Crataegusoxyacantha | Rat heart | Average prevalence of malignant arrhythmias (VF + Flutter); |
Makdessi et al., 1999 [68] | |
Average prevalence of VT; | ||||
TCR | Rat heart | Antioxidant enzyme activity; | Jayalakshim and Devaraj, 2004 [69] | |
| ||||
Antiarrhythmic effect | Crataegus meyeri extracts | Rat | Ventricular ectopic beats; | Garjani et al., 2000 [72] |
Single extrasystoles; | ||||
| ||||
Lipid-lowering effect | HFC | Mice | Blood lipids; | Xu et al., 2009 [76] |
(LDL-C)/TC; | ||||
TG levels; | ||||
HFC | Hamsters | Serum cholesterol; | Zhang et al., 2002 [78] | |
VLDL + LDL cholesterol; | ||||
Hepatic cholesterol ester content; | ||||
The leaf of Crataegus pinnatifida | Mice | TG and glucose absorption; | Wang et al., 2011 [79] | |
Gastrointestinal transit; | ||||
TG and free fatty acid; | ||||
Hawthorn flavonoids | Mice | LPL expression; | Fan et al., 2006 [80] | |
PPARγ-dependent mechanism; | ||||
TCR | Rat | Lipids in the serum and heart; | Akila and Devaraj, 2008 [81] | |
Lipid in liver and aorta; | ||||
Activity of antioxidant enzymes; | ||||
Whole plant of Crataegus | Zebrafish | Intravascular cholesterol levels; | Robert et al., 2012 [82] | |
| ||||
Decrease of arterial blood pressure | Crataegus tanacetifolia leaf extract | Rats coronary artery | L-NAME-induced hypertension; | Koçyõldõz et al., 2006 [83] |
Beneficial effects on cardiovascular system; | ||||
Aqueous extract of Crataegus | Rat | HR and MAP; | Shatoor, 2013 [84] | |
Sinus node suppression; | ||||
Atrioventricular blockade; Muscarinic receptor M2; | ||||
Blockade of beta-receptors; |
Notes: TCR: tincture of Crataegus; AEC: alcoholic extract of Crataegus oxycantha; Vcfc: velocity of circumferential shortening; TXB2: thromboxane B2; CE: Crataegus fruit extracts; CM: Crataegus microphylla; VT: ventricular tachycardia; TC: serum cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglyceride; HFC: hawthorn fruit compound; HR: heart rate; MAP: mean arterial pressure.